Home › NCT04639297

NeuroVision vs Standard Neuromonitoring

NeruoVision Versus Standard Hospital Neuromonitoring, Influence on the Rate of Neurologic Injury Following Spine Surgery? A Randomized Controlled Trial

Who can join

All ages · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Patients undergoing a primary single or multilevel lateral spinal surgery procedures for degenerative pathology Diagnosis: myelopathy, radiculopathy, myeloradiculopathy, central stenosis, foraminal stenosis herniated nucleus pulposus, degenerative disc disease, spondylosis, and osteophytic complexes
* Patients able to provide informed consent

Exclusion Criteria:

* Active infection
* Active or history of malignancy
* Spinal traumatic injury within the past 2 years

About the study

The purpose of this study is to perform a prospective, randomized, controlled clinical trial to assess the utility of IONM in patients undergoing primary, single or multilevel lateral spinal procedures. Subjects will be randomized to undergo a lateral spine surgery with the use of NeuroVision® IONM or conventional hospital based IONM to assess incidence of new-onset neurological injury.

What is being tested

• NeuroVision® IONM (device)
• Hospital Based IONM (device)

Sponsor: Rush University Medical Center · Participants: 148 · Started: Sep 28, 2020

Contact the study team

Official record on ClinicalTrials.gov — NCT04639297

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.